PFIZER INC Disposal Group, Including Discontinued Operation, Assets, Current
PFIZER INC (PFE) had Disposal Group, Including Discontinued Operation, Assets, Current of $167.00 million as of 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Balance Sheet › Assets › Assets, Current › Disposal Group, Including Discontinued Operation, Assets, Current
us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent · last filed 2021-02-25
- 2020-12-31: Disposal Group, Including Discontinued Operation, Assets, Current $167.00M.
- 2019-12-31: Disposal Group, Including Discontinued Operation, Assets, Current $4.22B; Disposal Group, Including Discontinued Operation, Assets, Current as first filed $21.00M.
- 2019-09-29: Disposal Group, Including Discontinued Operation, Assets, Current $29.00M.
- 2019-06-30: Disposal Group, Including Discontinued Operation, Assets, Current $9.88B.
| Period end | Disposal Group, Including Discontinued Operation, Assets, Current | Disposal Group, Including Discontinued Operation, Assets, Current as first filed |
|---|---|---|
| 2020-12-31 | $167.00M 10-K · filed 2021-02-25 | |
| 2019-12-31 | $4.22B 10-K · filed 2021-02-25 | $21.00M 10-K · filed 2020-02-27 |
| 2019-09-29 | $29.00M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $9.88B 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $9.88B 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $9.72B 10-K · filed 2020-02-27 | |
| 2018-04-01 | $64.00M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $12.00M 10-K · filed 2019-02-28 | |
| 2017-10-01 | $16.00M 10-Q · filed 2017-11-09 | |
| 2017-07-02 | $3.00M 10-Q · filed 2017-08-10 | |
| 2017-04-02 | $3.00M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $801.00M 10-K · filed 2018-02-22 | |
| 2016-10-02 | $1.12B 10-Q · filed 2016-11-10 | |
| 2015-12-31 | $9.00M 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |